Regulatory Crackdown on Prescription Drug Ads Sparks Market Concerns
The U.S. government plans to implement reforms requiring prescription drug ads to include full safety warnings, which could lead to reduced advertising spending on TV, negatively impacting broadcasters and media stocks like Nexstar, Disney, and Comcast. The changes aim to curb misleading advertising but may face legal and industry pushback, creating uncertainty about the future of pharmaceutical advertising on television.